Literature DB >> 23050065

Diabetic foot infections with osteomyelitis: efficacy of combined surgical and medical treatment.

Abubakr H Widatalla1, Seif Eldin I Mahadi, Mohamed A Shawer, Shadad M Mahmoud, A E Abdelmageed, Mohamed Elmakki Ahmed.   

Abstract

Diabetic foot infections are a high risk for lower extremity amputation in patients with dense peripheral neuropathy and/or peripheral vascular disease. When they present with concomitant osteomyelitis, it poses a great challenge to the surgical and medical teams with continuing debates regarding the treatment strategy. A cohort prospective study conducted between October 2005 and October 2010 included 330 diabetic patients with osteomyelitis mainly involving the forefoot (study group) and 1,808 patients without foot osteomyelitis (control group). Diagnosis of osteomyelitis was based on probing to bone test with bone cultures for microbiological studies and/or repeated plain radiographic findings. Surgical treatment included debridement, sequestrectomy, resections of metatarsal and digital bones, or toe amputation. Antibiotics were started as empirical and modified according to the final culture and sensitivities for all patients. Patients were followed for at least 1 year after wound healing. The mean age of the study group was 56.7 years (SD = 11.4) compared to the control group of 56.3 years (SD = 12.1), while the male to female ratio was 3:1. At initial presentation, 82.1% (n=271) of the study group had an ulcer penetrating the bone or joint level. The most common pathogens were Staphylococcus aureus (33.3%), Pseudomonas aeruginosa (32.2%), and Escherichia coli (22.2%) with an almost similar pattern in the control group. In the study group, wound healing occurred in less than 6 months in 73% of patients compared to 89.9% in the control group. In the study group, 52 patients (15.8%) had a major lower extremity amputation versus 61 in the control group (3.4%) (P=0.001). During the postoperative follow-up visits, 12.1% of patients in each group developed wound recurrence. In conclusion, combined surgical and medical treatment for diabetic foot osteomyelitis can achieve acceptable limb salvage rate and also reduce the duration of time to healing along with the duration of antibiotic treatment and wound recurrence rate.

Entities:  

Keywords:  amputation; diabetic foot; neuropathy; osteomyelitis; ulcer

Year:  2012        PMID: 23050065      PMCID: PMC3464066          DOI: 10.3402/dfa.v3i0.18809

Source DB:  PubMed          Journal:  Diabet Foot Ankle        ISSN: 2000-625X


Diabetic foot infections and osteomyelitis are common pathological entities with serious complications that can result in a lower extremity amputation. There is uncertainty about optimal treatment and probably substantial variation in many clinical practices. Osteomyelitis in the diabetic foot has been well described as a complication of a preexisting infected foot wound (1) and commonly found in diabetic patients with dense peripheral neuropathy. Staphylococcus aureus is the most common pathogen in diabetic foot osteomyelitis, followed by other aerobic Gram-positive cocci. Aerobic Gram-negative bacilli and anaerobes are occasionally isolated, often in mixed diabetic foot infections (2). The direct probing to bone test is fairly reliable in diagnosis of diabetic foot osteomyelitis, and in advanced cases, medical imaging studies may not be necessary in diagnosis. Selection of the appropriate antimicrobial therapy is best directed by biopsy, cultures, and sensitivities of the infected bone obtained during surgery. Antibiotic therapy should usually be given parenterally, at least initially, and continued for at least 6 weeks. Surgical debridement or resection of the infected bone, when feasible, improves the outcome. With appropriate antibiotic therapy, most cases of diabetic foot osteomyelitis can be successfully managed (2).

Patients and methods

A cohort prospective study was conducted between October 2005 and October 2010 in Jabir AbuEliz Diabetic Center (JADC), Khartoum, Sudan. It included 330 diabetic patients with foot osteomyelitis (study group) and 1,808 diabetic patients with a foot ulcer but without foot osteomyelitis (control group). All patients had an informed consent, and the study was approved by the ethical committee in JADC. Clinical assessment of all patients who presented to our outpatient clinic with diabetic foot ulcers included the probe-to-bone (PTB) test. The PTB test was performed using a sterile probe to palpate the suspicious osteomyelitic bone at the base of the wound. The diagnosis of osteomyelitis was based on the PTB (Fig. 1) along with a surgical bone specimen taken for microbiological studies. Repeated plain radiographic views were used to diagnose osteomyelitis and demonstrate bone destruction in addition to the follow-up for resolution of infection. Magnetic resonance imaging (MRI) and bone scintigraphy were only used selectively to differentiate between osteomyelitis and non-infective bone destruction in diabetic neuropathic patients.
Fig. 1

Clinical pictures (A, B) demonstrating the probe-to-bone test in our study.

Clinical pictures (A, B) demonstrating the probe-to-bone test in our study. Surgical treatment included debridement, sequestrectomy, metatarsal and/or phalangeal resection, or toe amputation (Fig. 2). Surgical debridement was performed in patients who had no critical limb ischemia, and minor amputations were performed for those with localized gangrene. In all patients, major limb ischemia was diagnosed both clinically and with vascular non-invasive studies of ankle brachial index < 0.9. Wound healing was allowed by secondary intention or in cases where extensive tissue and skin loss or the wound edges were too far apart for closure, acceleration of wound healing was achieved by minor plastic reconstructive procedures such as secondary sutures, skin grafts, and flaps (Figs. 3 and 4). Postoperative wound off-loading was initiated with fiberglass casting, initial bed rest, accommodative dressings, external fixation, assistant devices, therapeutic shoes, or total contact casting.
Fig. 2

Surgical resection and debridement of infected metatarsal and phalangeal bones (A, B).

Fig. 3

Intraoperative clinical pictures demonstrating the surgical probing to bone (A), partial bone resection (B), and wound closure (C).

Fig. 4

Surgical example of wound healing with local flap closure.

Surgical resection and debridement of infected metatarsal and phalangeal bones (A, B). Intraoperative clinical pictures demonstrating the surgical probing to bone (A), partial bone resection (B), and wound closure (C). Surgical example of wound healing with local flap closure. The minimal duration of antibiotic treatment was 6 weeks, and it varied according to the clinical and radiological evidence of infection resolution. The commonly used antibiotics were ceftriaxone, ceftazidime, gentamicin, amikacin, amoxicillin/clavulanic acid, and ciprofloxacin. An intravenous dose was administered initially for 3–7 days followed by oral intake. After wound healing, patients were followed for at least 1 year, and limb salvage was considered when no major lower extremity amputation was required. The data were analyzed using the SPSS program version 12. Statistical tests using student's t-test for numerical values and Chi square (χ 2) tests were utilized. A P value was considered significant when it was <0.05.

Results

Three hundred and thirty diabetic patients with foot osteomyelitis mainly in the forefoot (study group) and 1,808 diabetic patients without foot osteomyelitis (control group) were studied. Table 1 shows that both groups were matched for age only with more male predominance in the study group. Among the study group, 60.1% had diabetes for more than 10 years. Toes were involved in 1,192 patients from both groups (51%), metatarsal heads in 37.5%, and the heel in only 3%.
Table 1

Comparison between diabetic foot ulcerations with osteomyelitis (study group) and without osteomyelitis (control group)

Study groupControl groupTests of significance and risk ratio
Mean age (years)+standard deviation56.7+1156.3+12.1
Male:female ratio3:11:1.3
Type of diabetesYates χ 2=5.13; P=0.0235
 Type 2 N=267 (80.7%) N=1350 (74.7%)
 Type 1 N=64 (19.3%) N=458(25.3%)
Duration of wound healingYates χ 2=20.02; P=0.0002
  < 3 months42.4%72.7%
 3–6 months30.6%17.2%
 6 months to 1 year18.8%7.9%
  > 1 year8.2%2.2%
OutcomeYates χ 2=85.41; P<0.0001
 Limb salvage N=270 (81.8%) N=1735 (96%)
 Major amputation N=52 (15.8%) N=61 (3.4%)
 Deaths N=8 (2.4%) N=12 (0.7%)
Wound recurrence N=40 (12.1%) N=218 (12.1%) P=0.97; odds ratio = 1.005; CI = 0.732–1.378
Comparison between diabetic foot ulcerations with osteomyelitis (study group) and without osteomyelitis (control group) At initial presentation, 82.1% (n=271) of the osteomyelitis patients in the study group had an ulcer penetrating the bone or joint level (Wagner Grade 3 ulcer). The most common causative organisms for the study group were Staphylococcus aureus (33.3%), Pseudomonas aeruginosa (32.2%), and Escherichia coli (22.2%). In the remaining 59 patients from the study group (17.9%), the diagnosis of osteomyelitis was based on clinical finding of increased size of the toe (sausage toe) with repeated findings on plain radiographic views. Bone scintigraphy and MRI were used only in 53 patients from both study and control groups. In the control group, 87.2% of the ulcers initially presented with a Grade 2 or less Wagner ulcer, and the most common bacterial isolates were similar to that of the study group. Out of the patients with osteomyelitis, 61.2% had peripheral neuropathy compared to 50% in the control group (P=0.05; χ 2=3.84). Peripheral vascular disease was reported in 32.7% of the study group and in 28.8% of the control group (P=0.007). Diabetic neuropathic osteoarthropathy was reported in 11 cases (3.3%) of the study group and in 48 patients in the control group (2.7%). Management entailed partial sequestrectomy for necrotic bone combined with long-term antibiotics for 6–8 weeks based on the results of bacteriological cultures and sensitivities. The degree of bone resection varied from minor excision of necrotic bone up to complete removal of the digital bones. In the study group, toes were affected in 237 patients (71.6%) versus 955 in the control group (53%). Toe amputation was performed in 116 patients in the study group (35%) versus 355 in the control group (19%) (P=0.001). The hallux was the most common digit to be amputated (n=35), which represented 10.6% of the study group. Wound healing in the study group occurred within less than 6 months in 73% of patients compared to 89.9% in the control group (P=0.0002) (Table 1). In the study group, limb salvage was achieved in 81.8% compared to 96% in the control group (P=0.0001). In the study group, 52 patients (15.8%) had a major lower extremity amputation caused by deep infection and extensive tissue necrosis in 40 patients, and peripheral vascular disease in the remaining 12 patients. In addition, there was no significant difference in the incidence of wound recurrence between the two groups during 1 year of follow-up (Table 1).

Discussion

Diabetic foot infections account for a substantial global burden of morbidity, psychosocial disruption, and economic cost. Recommendations for best practice are continuously evolving in parallel with improvements in medical imaging modalities, development and clinical use of new antimicrobial agents, and data surrounding novel wound-healing adjunctive strategies (3). In developing countries, patients usually present late for treatment with devastating complications of the advanced diabetes mellitus disease. In those cases of diabetic foot osteomyelitis with an ulcer presentation that can be probed to the bone level, imaging studies may rarely be used. The PTB test with bone specimen collection taken for microbiological culture, sensitivities, and/or biopsy is very reliable, and the diagnosis of osteomyelitis can confidently be established particularly if the underlying bone is necrotic and friable in consistency (1, 4–6). PTB testing should be included in the initial assessment of all diabetic patients with infected pedal ulcers (7). In our study, a common presentation we encountered was a sizable sausage-shaped toe, the appearance of which should alert the physician to the possibility of underlying osteomyelitis (8). In few cases, there is a diagnostic difficulty to differentiate between osteomyelitis and neuropathic osteoarthropathy especially when there is no wound and PTB testing cannot be performed. In these cases, repeated plain radiographs, MRI, and/or bone scintigraphy may be needed. In many previous studies, MRI is thought to be the most accurate imaging tool to diagnose osteomyelitis (9–14). It has been shown that surgical resection of the infected and necrotic bone favors a good outcome in chronic osteomyelitis (15–18) and that careful assessment of the patient's lower extremity vascular and neurological status is necessary before any surgical intervention (19, 20). Surgical treatment in our study group included sequestrectomy and debridement of necrotic and friable bone to healthy bone margins. In some cases, more extensive surgical debridement in the form of partial resection of the metatarsal bone or even phalangeal bones was performed. Surgical excision of the infected bone provided reliable specimens for microbiological and histopathological analysis. Minor amputations were performed if there was an extensive localized soft tissue necrosis provided that there was no critical ischemia. Published data have reported that diabetic foot osteomyelitis, in the absence of extensive necrosis or gangrene, usually responds to antimicrobial therapy without the need for an ablative surgical procedure (21). Venkatesan et al. have also reviewed the management of osteomyelitis in a multidisciplinary diabetic foot clinic and reported that the success of conservative therapy with prolonged course of oral antibiotics challenges conventional advice that excision of infected bone is essential in the management of osteomyelitis in diabetic patients (22). In our study, we have found that surgical sequestrectomy combined with prolonged oral antibiotic therapy gave the best results for the patients with diabetic foot osteomyelitis. This combined method may reduce the changes in biomechanical alterations of the diabetic foot and minimize the duration of antibiotic therapy. However, more research including studies of adjunctive therapies in cases of bone infection in the feet of diabetic patients is required (23). The choice of antibiotic therapy is best guided by a bone biopsy or debridement culture results (19). Parenteral therapy is needed for severe infections, but oral therapy is adequate for most mild or moderate diabetic foot infections (24). In our study group, bone specimens for culture and sensitivities to identify the causative pathogens were obtained after the surgical wound debridement in order to avoid contamination results. Staphylococcus aureus was the most common pathogen to be isolated from our specimens, which was in agreement with most international reports (1, 15, 22, 25), but a higher than usual incidence of Pseudomonas aeruginosa osteomyelitis was noticed. Patients received antibiotics according to the results of culture and sensitivity for at least 6 weeks. Initially, broad-spectrum intravenous antibiotics were used in the presence of a severe diabetic foot infection until the final microbiological results were received. In moderate or mild diabetic foot infections, oral antibiotics were used. The duration of antibiotics depended on the clinical, microbiological, and radiological evidence of infection control. When infection was adequately eradicated, the antibiotics treatment was discontinued even in the presence of a wound. Non-infected wounds can heal if appropriate wound care with regular wound dressings are performed, and antibiotic therapy is not usually indicated in clinically non-infected wounds (17, 26). The duration of antibiotic therapy may be shortened considerably after surgical intervention (27). Split thickness skin grafting has also been shown to be an effective method of managing diabetic foot ulcers as compared to conservative wound dressings by reducing healing times and length of hospital stay with minimal donor-site morbidity (28). After surgical debridement, off-loading played an important role for our postoperative care. Relieving pressure on the ulcerated area is absolutely crucial in the treatment of the diabetic foot to prevent further trauma, reduce any shearing forces to the area, and facilitate wound healing. Diabetic limb salvage was obtained in a considerable number of patients with osteomyelitis with a combined surgical and antibiotic treatment. However, we reported a significantly higher incidence of major amputation in the study group. This may be considered due to the more extensive tissue necrosis, bone and joint destruction, and loss of normal foot structure that presented in the study group with diabetic foot osteomyelitis. The hallux was also found to be the most common site affected in the study group (29). In addition, both groups had almost similar wound recurrence rates during the postoperative period.

Conclusion

In developing countries, due to the delayed presentation of a diabetic foot complication, initial medical imaging studies may rarely be used. Combined surgical and medical treatment can achieve acceptable diabetic limb salvage rates and also reduce the duration of time to healing, duration of antibiotic treatment, and wound recurrence.
  29 in total

1.  Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?

Authors:  J Aragón-Sánchez; Benjamin A Lipsky; J L Lázaro-Martínez
Journal:  Diabet Med       Date:  2011-02       Impact factor: 4.359

Review 2.  Osteomyelitis of the foot in diabetic patients.

Authors:  B A Lipsky
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

3.  'Sausage toe': a reliable sign of underlying osteomyelitis.

Authors:  S M Rajbhandari; M Sutton; C Davies; S Tesfaye; J D Ward
Journal:  Diabet Med       Date:  2000-01       Impact factor: 4.359

Review 4.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients.

Authors:  M L Grayson; G W Gibbons; K Balogh; E Levin; A W Karchmer
Journal:  JAMA       Date:  1995-03-01       Impact factor: 56.272

6.  Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis.

Authors:  Marie T Dinh; Cybele L Abad; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

7.  Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy.

Authors:  D M Bamberger; G P Daus; D N Gerding
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

8.  Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging.

Authors:  W T Yuh; J D Corson; H M Baraniewski; K Rezai; A R Shamma; M H Kathol; Y Sato; G Y el-Khoury; D R Hawes; C E Platz
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

Review 9.  Diabetic foot infection.

Authors:  Mazen S Bader
Journal:  Am Fam Physician       Date:  2008-07-01       Impact factor: 3.292

Review 10.  Diabetic foot osteomyelitis.

Authors:  A Hartemann-Heurtier; E Senneville
Journal:  Diabetes Metab       Date:  2008-01-31       Impact factor: 6.041

View more
  4 in total

Review 1.  Diabetic Foot Infections: Update on Management.

Authors:  Maria Nikoloudi; Ioanna Eleftheriadou; Anastasios Tentolouris; Ourania A Kosta; Nikolaos Tentolouris
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

2.  Blue Laser Inhibits Bacterial Growth of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

Authors:  Natanael Teixeira Alves de Sousa; Marcos Ferracioli Santos; Rosana Caetano Gomes; Hugo Evangelista Brandino; Roberto Martinez; Rinaldo Roberto de Jesus Guirro
Journal:  Photomed Laser Surg       Date:  2015-05       Impact factor: 2.796

3.  Diagnosing osteomyelitis in the diabetic foot: a pilot study to examine the sensitivity and specificity of Tc(99m) white blood cell-labelled single photon emission computed tomography/computed tomography.

Authors:  Mallory M Przybylski; Samantha Holloway; Steven D Vyce; Antonio Obando
Journal:  Int Wound J       Date:  2014-06-26       Impact factor: 3.315

Review 4.  Optimal management of diabetic foot osteomyelitis: challenges and solutions.

Authors:  José Luis Lázaro Martínez; Yolanda García Álvarez; Aroa Tardáguila-García; Esther García Morales
Journal:  Diabetes Metab Syndr Obes       Date:  2019-06-21       Impact factor: 3.168

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.